These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 29010028)

  • 21. [Efficient schemes for treating pulmonary tuberculosis with isoniazid under bacteriostatic concentration control].
    Sushkin AG; Guzeeva SA; Kanevskaia SS
    Probl Tuberk; 1976 Jun; (6):53-7. PubMed ID: 1005420
    [No Abstract]   [Full Text] [Related]  

  • 22. [Respiratory infections research: a perspective from the tuberculosis and respiratory infections area (TIR)].
    Jesús Cremades M; Luiza de Souza-Galvão M; García JM; Menéndez R
    Arch Bronconeumol; 2009; 45 Suppl 1():11-5. PubMed ID: 19303524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 24. [The course and treatment and efficiency of surgical treatment for disseminated pulmonary tuberculosis].
    Kuz'mina NV; Musatova NV; Mel'nikov EV
    Probl Tuberk Bolezn Legk; 2009; (2):38-42. PubMed ID: 19382641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fundamental principles of diagnosis, differential diagnosis and treatment of ocular tuberculosis].
    Ustinova EI
    Vestn Oftalmol; 2001; 117(3):38-41. PubMed ID: 11521436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of 2 therapeutic schemes in pulmonary tuberculosis not previously treated].
    Galleguillos F; Valenzuela P; Carrasco E; Ham O; Ihnen R
    Rev Med Chil; 1973 Jan; 101(1):25-9. PubMed ID: 4753547
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutaneous tuberculosis diagnosis in an inhospitable Amazonian region by means of telemedicine and molecular biology.
    Angel DI; Alfonso R; Faizal M; Ricaurte O; Baez JA; Rojas A; Barato P; Patarroyo ME; Patarroyo MA
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S65-8. PubMed ID: 15858512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Variations of transaminases and blood sugar in pulmonary tuberculosis patients under different chemotherapy schemes].
    Rosemberg J; Dini W; Accetozi M; Cassoni Tde A; Inaco BJ; Garlipp W; Romanoff JS
    AMB Rev Assoc Med Bras; 1974 Jul; 20(7):243-8. PubMed ID: 4547118
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro antimycobacterial activities of Physalis angulata L.
    Pietro RC; Kashima S; Sato DN; Januário AH; França SC
    Phytomedicine; 2000 Jul; 7(4):335-8. PubMed ID: 10969728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective tuberculosis control and health sector reforms in Kenya: challenges of an increasing tuberculosis burden and opportunities through reform.
    Hanson C; Kibuga D
    Int J Tuberc Lung Dis; 2000 Jul; 4(7):627-32. PubMed ID: 10907765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The virulence factors of Mycobacterium tuberculosis: genetic control, new conceptions].
    Prozorov AA; Fedorova IA; Bekker OB; Danilenko VN
    Genetika; 2014 Aug; 50(8):885-908. PubMed ID: 25731019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of smear negative pulmonary tuberculosis among patients visiting St. Peter's Tuberculosis Specialized Hospital, Addis Ababa, Ethiopia.
    Desta K; Asrat D; Lemma E; Gebeyehu M; Feleke B
    Ethiop Med J; 2009 Jan; 47(1):17-24. PubMed ID: 19743776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An adult zebrafish model for preclinical tuberculosis vaccine development.
    Oksanen KE; Halfpenny NJ; Sherwood E; Harjula SK; Hammarén MM; Ahava MJ; Pajula ET; Lahtinen MJ; Parikka M; Rämet M
    Vaccine; 2013 Oct; 31(45):5202-9. PubMed ID: 24055305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effector memory T-cells dominate immune responses in tuberculosis treatment: antigen or bacteria persistence?
    Tapaninen P; Korhonen A; Pusa L; Seppälä I; Tuuminen T
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):347-55. PubMed ID: 20132627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of BCG-induced lymphadenitis from tuberculosis in lymph node biopsy specimens by molecular analyses of pncA and oxyR.
    Yan JJ; Chen FF; Jin YT; Chang KC; Wu JJ; Wang YW; Su IJ
    J Pathol; 1998 Jan; 184(1):96-102. PubMed ID: 9582534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of spinal tuberculosis with ultrashort-course chemotherapy in conjunction with partial excision of pathologic vertebrae.
    Wang Z; Ge Z; Jin W; Qiao Y; Ding H; Zhao H; Lin Z; Chen J; Yang W
    Spine J; 2007; 7(6):671-81. PubMed ID: 17998127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incident reporting schemes and the need for a good story.
    Rooksby J; Gerry RM; Smith AF
    Int J Med Inform; 2007 Jun; 76 Suppl 1():S205-11. PubMed ID: 16959537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality Assurance schemes.
    Wood JD; Holder JS; Main DC
    Meat Sci; 1998; 49S1():S191-203. PubMed ID: 22060711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development in harmonisation of proficiency testing (for vapours, gasses, and dusts) in the European Union.
    Stacey P; Tylee B
    Arh Hig Rada Toksikol; 1998 Dec; 49(4):307-17. PubMed ID: 10356842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate biopsy schemes: 3-D visualization-based evaluation.
    Zeng J; Bauer J; Zhang W; Sesterhenn I; Moul J; Mun SK
    Stud Health Technol Inform; 1999; 62():390-1. PubMed ID: 10538396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.